FI106206B - Menetelmä polypeptidin valmistamiseksi - Google Patents

Menetelmä polypeptidin valmistamiseksi Download PDF

Info

Publication number
FI106206B
FI106206B FI920889A FI920889A FI106206B FI 106206 B FI106206 B FI 106206B FI 920889 A FI920889 A FI 920889A FI 920889 A FI920889 A FI 920889A FI 106206 B FI106206 B FI 106206B
Authority
FI
Finland
Prior art keywords
ala
gly
pro
cys
leu
Prior art date
Application number
FI920889A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI920889A0 (fi
Inventor
Ei Mochida
Akio Uemura
Atsushi Nii
Hideaki Morishita
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of FI920889A0 publication Critical patent/FI920889A0/fi
Application granted granted Critical
Publication of FI106206B publication Critical patent/FI106206B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/7455Thrombomodulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI920889A 1990-06-27 1992-02-27 Menetelmä polypeptidin valmistamiseksi FI106206B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP16876690 1990-06-27
JP16876690 1990-06-27
PCT/JP1991/000873 WO1992000325A1 (fr) 1990-06-27 1991-06-27 Polypeptides anticoagulants
JP9100873 1991-06-27

Publications (2)

Publication Number Publication Date
FI920889A0 FI920889A0 (fi) 1992-02-27
FI106206B true FI106206B (fi) 2000-12-15

Family

ID=15874056

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920889A FI106206B (fi) 1990-06-27 1992-02-27 Menetelmä polypeptidin valmistamiseksi

Country Status (8)

Country Link
US (2) US5516659A (fr)
EP (1) EP0489180A4 (fr)
JP (1) JP3189052B2 (fr)
AU (1) AU643306B2 (fr)
CA (1) CA2065409C (fr)
FI (1) FI106206B (fr)
NO (1) NO302527B1 (fr)
WO (1) WO1992000325A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0816495A1 (fr) * 1987-01-08 1998-01-07 Asahi Kasei Kogyo Kabushiki Kaisha ADN codant pour un peptide favorisant l'activation de la protéine C par la thrombine, procédé pour sa préparation
DE69433133T2 (de) * 1993-12-17 2004-04-01 Mochida Pharmaceutical Co. Ltd. Lösliches thrombomodulin enthaltende zubereitung
US6465620B1 (en) * 2000-01-21 2002-10-15 Hyseq, Inc. Methods and materials relating to novel von Willebrand/Thrombospondin-like polypeptides and polynucleotides
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7510845B2 (en) * 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US7691604B1 (en) 2000-05-04 2010-04-06 California Institute Of Technology MRG polypeptides and nucleic acids encoding the same
US20030152941A1 (en) * 2000-06-21 2003-08-14 Boyle Bryan J. Nucleic acids encoding novel von Willebrand/Thrombospondin factor-like polypeptides and uses of same
WO2002009647A2 (fr) * 2000-07-28 2002-02-07 Emory University Composant biologique comprenant une membrane artificielle
ATE304021T1 (de) * 2001-05-25 2005-09-15 Vlaams Interuniv Inst Biotech Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon
JP4187141B2 (ja) * 2002-04-12 2008-11-26 興和株式会社 新規なトロンボモジュリン発現促進剤
US20040121410A1 (en) * 2002-12-20 2004-06-24 Anderson David J. Pain signaling molecules
BRPI0720158A2 (pt) 2006-10-06 2014-05-20 Asahi Kasei Pharma Corp Agentes para terapia e/ou melhora de coagulação intravascular disseminada, para reduzir a probabilidade de morte em pacientes sofrendo da mesma, métodos para selecionar pacientes, e, para tratar e/ou melhorar coagulação intravascular disseminada
TW201431872A (zh) 2007-03-23 2014-08-16 Asahi Kasei Pharma Corp 高純度可溶性凝血酶調節素之製造方法
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
MX2011005005A (es) * 2008-11-12 2011-05-25 Lilly Co Eli Composiciones y metodos de uso para variantes de trombomodulina.
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および/または治療剤
AU2011246021B2 (en) 2010-04-30 2014-03-13 Asahi Kasei Pharma Corporation High-purity soluble thrombomodulin and method for producing same
AU2011287360A1 (en) 2010-08-05 2013-02-21 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties
US9592275B2 (en) 2011-11-15 2017-03-14 Asahi Kasei Pharma Corporation Medicament for therapeutic treatment and/or improvement of sepsis
RU2595857C2 (ru) 2012-05-31 2016-08-27 Кинки Юниверсити Средство для профилактического и/или терапевтического лечения периферической нейропатической боли, вызываемой противораковым средством
US11497795B2 (en) 2018-09-28 2022-11-15 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
CA3116686A1 (fr) 2018-10-22 2020-04-30 Asahi Kasei Pharma Corporation Medicament pour le traitement therapeutique et/ou l'amelioration des sepsies accompagnees de coagulopathie
CN114686443B (zh) * 2020-12-31 2023-11-03 广州万孚生物技术股份有限公司 杂交瘤细胞、抗血栓调节蛋白单克隆抗体及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
ES2065318T3 (es) * 1986-07-15 1995-02-16 Kowa Co Sustancia que se une a trombina y procedimiento para su preparacion.
JPS63146898A (ja) * 1986-07-15 1988-06-18 Kowa Co トロンビン結合性物質およびその製法
JPS6330423A (ja) * 1986-07-22 1988-02-09 Kowa Co トロンビン結合性物質およびその製法
EP0816495A1 (fr) * 1987-01-08 1998-01-07 Asahi Kasei Kogyo Kabushiki Kaisha ADN codant pour un peptide favorisant l'activation de la protéine C par la thrombine, procédé pour sa préparation
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
DK299087D0 (da) * 1987-06-12 1987-06-12 Novo Industri As Proteins and derivatives thereof
JPH0219399A (ja) * 1988-07-05 1990-01-23 Oklahoma Medical Res Found トロンビン結合ポリピペプチド
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
US5273962A (en) * 1990-11-30 1993-12-28 Kowa Co., Ltd. Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site

Also Published As

Publication number Publication date
US5695964A (en) 1997-12-09
EP0489180A1 (fr) 1992-06-10
NO920762D0 (no) 1992-02-26
EP0489180A4 (en) 1993-03-31
FI920889A0 (fi) 1992-02-27
NO302527B1 (no) 1998-03-16
JP3189052B2 (ja) 2001-07-16
AU643306B2 (en) 1993-11-11
CA2065409A1 (fr) 1991-12-28
US5516659A (en) 1996-05-14
NO920762L (no) 1992-04-24
CA2065409C (fr) 2002-05-14
AU8080091A (en) 1992-01-23
WO1992000325A1 (fr) 1992-01-09

Similar Documents

Publication Publication Date Title
FI106206B (fi) Menetelmä polypeptidin valmistamiseksi
JP2515468B2 (ja) ヒト抗トロンビンiii
US8143027B2 (en) Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity
AU621358B2 (en) Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
EP0775711B1 (fr) Peptide a action inhibant l'agregation plaquettaire et procede de production de ce compose
US5238919A (en) Peptides that inhibit von Willebrand Factor binding to the platelet SPIB receptor
EP0511393B1 (fr) Mutant d'hirudine, sa production, anticoagulant, vecteur secretoire, microorganisme transforme par ledit vecteur et production d'un produit a partir dudit microorganisme
JP3805358B2 (ja) フォン・ウィルブランド因子の治療用ドメイン
WO1991012270A2 (fr) Nouveaux inhibiteurs d'agregation plaquettaires obtenus a partir de sangsue
AU661515B2 (en) Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
JPH04505554A (ja) 可溶性トロンボモジュリン類似体
RU2183214C2 (ru) Природный и рекомбинантный ингибиторы тромбина, их получение и применение
JPH08511948A (ja) C4bp結合活性が不足しているがapc補因子活性を有するプロテインs欠失変異体、組成物及び治療法
EP0395375B1 (fr) Séquence d'ADN codant pour des polypeptides assimilables à l'ancrod et compositions comprenant les produits d'expression de celles-ci
CA2004764C (fr) Proteines ancrod, leur preparation et leur utilisation
NO317661B1 (no) Trombinaktiverbare plasminogenanaloger, anvendelse av forbindelsene ved fremstilling av et farmasoytisk middel, preparater som omfatter forbindelsene, samt nukleinsyre
FI102844B (fi) Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasmin ogeenin aktivaattori
US5273962A (en) Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site
JPH04210700A (ja) 組換ヒトトロンボモジュリン誘導体
WO1993011778A1 (fr) Molecules anti-thrombotiques bifonctionnelles et polypetptides anti-trhombotiques
CA2083286C (fr) Fibrinogenogenases recombinants, leur preparation et leur utilisation
CA2094259A1 (fr) Fragments therapeutiques du facteur de von willebrand
CA2056005C (fr) Substance liant la thrombine et procede de preparation
DE69921951T2 (de) Thromben-spezifische Streptokinasen mit veränderten plasminogen-aktivierenden Eigenschaften und ein Verfahren zu deren Herstellung
JPH04197184A (ja) トロンビン阻害活性を有する新規ポリペプチドおよびその製造法